POPULARITY
Categories
Thank you to our Sponsors: West Peak and True Classic!- Upgrade your wardrobe and save on @TrueClassic at https://trueclassic.com/SALTY #trueclassicpod This week on Pinch My Salt we dive into the wild side of surf culture — surf fights at Lower Trestles, drone pilots disrupting lineups, Florida surf history, and why surfers never quite get the respect they deserve. Sterling Spencer and Ryan Spencer break down legendary run-ins at Lowers with Wardo, Dane Ward, Chad Montgomery, Fur Dog, and a lifeguard named Rocky who might still be looking for Sterling years later. From surf beefs to split peaks, this episode is packed with hilarious core-lord stories that only true surfers know.We also get into the rise of drone clips and how adult beginner surfers with drones are buying their way into the lineup, changing surf etiquette, and manipulating pros with the power of footage. Sterling reveals why clips are “currency” in surf culture, and why surfers will do anything for the right angle.From Florida's forgotten surf heroes to why there should be a Gulf Coast Surf Hall of Fame, we talk surf history, surf respect, and how the core lords of the sport never get the recognition they deserve. Plus — kickflip struggles, tattoos, kids' contests that felt like rooster fights, and how generational parenting shaped surfing.#PinchMySalt #SurfComedy #SurfPodcast #SterlingSpencer #RyanSpencer #Surfing #FloridaSurfers #SurfCulture #SurfLife #SurfHistory #SurfStories #SurfFight #DronePilots #SurfPodcastClips #CoreLord #SurfingLife #ComedyPodcast
It seems that every month or so a new “killer app” is launched with expectations that it will soon revolutionize the financial services industry. In spite of obvious benefits, most advisors seem to be “late adopters” of new technologies. Scott and Ken explore why it is hard for most people to embrace new ideas, and consider what an advisor can do if they want to accelerate their use of technologies in their business. Also in this episode, the AllianceBernstein Digital Coach – see practice management solutions for advisor success: abfunds.com/go/digitalcoach DISCLAIMER Note to All Readers: The information contained here reflects the views of AllianceBernstein L.P. or its affiliates and sources it believes are reliable as of the date of this podcast. AllianceBernstein L.P. makes no representations or warranties concerning the accuracy of any data. There is no guarantee that any projection, forecast or opinion in this material will be realized. Past performance does not guarantee future results. The views expressed here may change at any time after the date of this podcast. This podcast is for informational purposes only and does not constitute investment advice. AllianceBernstein L.P. does not provide tax, legal or accounting advice. It does not take an investor's personal investment objectives or financial situation into account; investors should discuss their individual circumstances with appropriate professionals before making any decisions. This information should not be construed as sales or marketing material or an offer or solicitation for the purchase or sale of any financial instrument, product or service sponsored by AllianceBernstein or its affiliates.
What if Flight MH370 wasn't just lost, but simply became hidden from view? In this episode with controversial youtuber Ashton Forbes, we take the mystery seriously: not as magic, but as a challenge to what we think we know about plasma, quantum mechanics, and fusion. The question isn't about belief, but about possibility: if teleportation happened, what physical mechanisms could explain it? We're at the edge of reason for this one, where mystery bashes up again rationality.PATREON https://www.patreon.com/c/demystifysciPARADIGM DRIFThttps://demystifysci.com/paradigm-drift-showOUR HOMEBREWED MUSICCheck out our band's new album:https://secretaryofnature.bandcamp.com/album/everything-is-so-good-hereVinyl pre-orders available now: https://buy.stripe.com/14A5kC3Od5d21Ms7zPdEs09Ashton's YT Channel: https://www.youtube.com/@UCHmFQzkpaJBSDD1PPFhPPSg 00:00 Go! Introduction to Mysteries and Theories 00:06:09 Shadowy Experiences with NASA and LENR 00:10:53 Exploring Alternative Models for Energy Production 00:15:12 Secrecy and the Potential of Fusion Technologies 00:19:04 Enthusiasm and Skepticism in Energy Research 00:19:33 Fusion Funding and Accountability 00:23:02 Hypothetical Fusion and UFOs 00:29:07 Teleportation Theories and Their Implications 00:34:00 Espionage and Disappearance of Flight MH370 00:37:41 MH370 Emergency Communication and Eyewitness Accounts 00:40:00 Analysis of the Standard Narrative and Government Response 00:44:00 Military Tracking and Discrepancies in Reports 00:48:00 Satellite Evidence and Pinging Issues 00:52:00 Theories of Time Manipulation and Disappearance 00:54:00 Controversy Over Diego Garcia and Missing Evidence 00:56:00 Examination of Internet Misinformation 01:01:00 Impact of War and Accountability 01:05:00 Perception of Reality and The Nature of Truth 01:09:00 Gatekeeping Technological Advances 01:17:00 Aspirations in Technology and Public Perception 01:20:00 Public Distrust and Technology Disclosure 01:24:00 Alien Technology and Interstellar Travel 01:27:00 Theoretical Physics and Mediums of Travel 01:30:00 Teleportation and Energy Conversion Theories 01:32:07 Medium of Travel and Ether Concept 01:34:51 The Nature of Invisibility and Coupling 01:39:12 Theoretical Concepts of Wormholes and Energy Requirements 01:41:28 Material vs. Abstract in Physics 01:46:05 Validity of Advanced Technologies and Science 01:48:45 Understanding Electricity's Nature 01:50:51 Energy and Motion in Physics 01:52:41 Magic vs. Physics 01:54:58 Perception and Quantum Reality 01:58:01 Connectivity and Spacetime 02:01:30 The Role of Medium and Interpretation 02:05:54 Future of Rational Inquiry 02:09:15 Understanding Substructure in Physics 02:12:31 The Search for Ether 02:14:49 Advancements in Fusion Technology 02:18:18 Free Energy Challenges and Insights 02:20:38 Government and Scientific Disinformation 02:25:01 The Intersection of Physics and Secrecy 02:27:06 Disclosure and New Technologies 02:30:06 Innovations in Free Energy Technologies 02:35:01 Merging Physics and Spirituality 02:40:06 Open Dialogue and Friendship #quantumphysics, #quantummechanics , #Astrophysics, #TheoreticalPhysics, #PlasmaPhysics, #Teleportation, #AviationMystery, #FlightMH370, #PhysicsExplained, #NewPhysics, #fusion , #PhysicsCommunity, #BigQuestions #philosophypodcast , #sciencepodcast, #longformpodcast
This episode is part of our EEI 2025 Highlights series. In this episode, you will hear conversations about keeping costs as low as possible for customers, how drones are enhancing electric company operations, advanced nuclear, and new technologies that are strengthening grid resilience. The speakers are: Mary Sprayregen, Global Head of Regulatory Affairs & Market Development, Oracle Utilities Tom Keefe, Vice Chair and Power, Utilities & Renewables Sector Leader for Deloitte Chris Levesque, President and CEO, TerraPower Duke Austin, President and CEO, Quanta You can also visit EEI's website to read EEI 2025 recap newsletters, see photos from our annual thought leadership forum, and watch videos from some of the keynotes.
If you experience chronic depression, anxiety, and pain, you likely dream of what life might look like, were you to find effective treatment and ongoing symptom relief. You may even fear your current challenge will last forever. But what if there was a drug-free way to experience significant and lasting relief? Is that even possible? According to Tom Kerber, founder and president of SunPowerLED, for many people, the answer is yes. Listen to learn about a powerful technology he believes God led him to develop, how this has helped him and his wife personally, along with examples of others who are experiencing flourishing life for the first time in years, if not decades. Find out more, read about the science behind the product and research conducted: At SunPowerLED.com SunPowerLED's YouTube Channel Watch testimonial videos HERE. And follow me on social media to hear my ongoing journey using the SuperPalm device for pain relief! Find Jennifer Slattery: On her website Instagram Facebook Amazon Subscribe to her free newsletter Discussion/Reflective Questions: What most resonated with you in this episode? What is your experience of or knowledge related to infared or near infared technology? When are you most apt to project today's challenge onto your future? Why might it be important to hold tight to hope? What would you day and life look like, were you to experience healing? What is one action step God might be inviting you to take having listened to this episode? Discover more Christian podcasts at lifeaudio.com and inquire about advertising opportunities at lifeaudio.com/contact-us.
Topics discussed on today's show: Never Gonna Do That Again, Birthdays, History Quiz, Death, Scottie Scheffler, Space, Schizophrenia Genes, 20 in 25, New Technology, Calling Out Of Work Excuses, Well That's Embarrassing, and Apologies.
This week's podcast is about generative AI strategy. And it's my summary of some key points of Sangeet Choudary's book "Reshuffle: Who wins when AI restacks the knowledge economy".You can listen to this podcast here, which has the slides and graphics mentioned. Also available at iTunes and Google Podcasts.Here is the link to the TechMoat Consulting.Here is the link to our Tech Tours.My take-aways are:GenAI's Biggest Impact Will Be as a New Technology for Coordination.GenAI Coordination Happens at 3 Levels (Shipping Container Example).GenAI is Dramatically Increasing What Can Be Coordinated. And How (OTA and Construction Examples).GenAI Will Impact How Firms Coordinate Knowledge. And Will Create Brains for Organizations.Photo by Sanket Mishra on Unsplash--------I am a consultant and keynote speaker on how to accelerate growth with improving customer experiences (CX) and digital moats.I am a partner at TechMoat Consulting, a consulting firm specialized in how to increase growth with improved customer experiences (CX), personalization and other types of customer value. Get in touch here.I am also author of the Moats and Marathons book series, a framework for building and measuring competitive advantages in digital businesses.This content (articles, podcasts, website info) is not investment, legal or tax advice. The information and opinions from me and any guests may be incorrect. The numbers and information may be wrong. The views expressed may no longer be relevant or accurate. This is not investment advice. Investing is risky. Do your own research.Support the show
Remember that magical moment in December 2015 when Kelly unveiled his wave pool to the world? In this episode of the WavePoolMag podcast, we dive into the full backstory behind that unforgettable day. We speak with Alex Poirot to learn more about working with Kelly, his first impressions of the now-famous wave, and the significance of that moment in surfing. You'll also hear how Alex and Brett Portero are pioneering an entirely new technology at Crest Surf Clubs.
This episode is sponsored by DeVere Chemical
Hour 2 of The Plank Show with Chris Plank and Blake Gamble starts with a discussion on new technology the NFL is experimenting with during the preseason. Then the Top 25 Countdown of the Associated Plank poll continues on - and the #21 team is the Iowa State Cyclones. Last but not least, today's Blake's Take asks: What's your favorite retro arcade or video game?
The Idaho Urologic Institute introduced a procedure that gives doctors a non-invasive way to target prostate cancer.
Cumberland Police have announced they are deploying a new tool to end vehicle chases safer. Indianapolis is one of five new hub locations announced for the U.S. Department of Agriculture. The number of Indiana high schoolers who go straight to college has reached a record low. Indianapolis's struggling animal care agency is one step closer to having a new leader. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. WFYI News Now is produced by Drew Daudelin, Zach Bundy and Abriana Herron, with support from News Director Sarah Neal-Estes.
This session dives into innovative machine perfusion techniques, advanced perfusates, and logistics breakthroughs aimed at extending organ viability and improving transplant outcomes. Packed with real-world case studies, expert insights, and interactive Q&A, this focused 1.2‑CEU webinar spotlights how modern technology is revolutionizing the way donor organs are preserved, transported, and ultimately saved.
In the previous episode, we spoke with Dr. Petar Prpic about how he built his specialty lens clinic (Prpic Eyecare). In that discussion, Dr. Prpic touched on some of the challenges he faced in his journey to developing his expertise in the realm of specialty contact lenses. In the second part of this discussion, we dive deeper into one of the most common challenges that all ECPs face (not just specialty lens providers); higher order aberrations (HOAs). In this episode, we discuss what the difference is between regular aberrations and HOAs. How does a patient who is suffering from HOAs present? What are their symptoms and complaints? And, ultimately, how can we help these patients who can't seem to get the resolution (literally and figuratively) that I looking for? This episode is sponsored by Ovitz. Learn more about the Ovitz xwave Aberrometer at www.Ovitz.usLove the show? Subscribe, rate, review & share! http://www.aboutmyeyes.com/podcast/
On this episode of SPOT Radio, Charlie Webb, CPPL, speaks with Karen Goelst. Karen and Charlie dive into strategies for building consensus across departments. By presenting a multi-benefit sales proposition—one that speaks to the priorities of clinical teams, procurement officers, and risk managers alike—they explore how layering value can break through resistance and foster collaborative buy-in.About Karen Goelst: As CEO of KleenEdge, a company specializing in privacy curtain compliance software and patented “no-ladder” exchange solutions, our focus is on empowering hospitals with cost-saving, innovations that get patient curtains exchanged on time.With over 14 years in architectural specialties we leverage lean, safe workflows along with technology to mitigate healthcare-acquired infections ensuring patient and staff safety.KleenEdge has pioneered software that empowers on-time curtain exchanges while providing actionable data. Our mission centers on delivering safety-driven, cost-saving, tools that address compliance and infection control challenges while supporting hospitals in optimizing their resources effectively.Karen Goelst Email: kgoelst@KleenEdge.com Roadtrip webpage: www.kleenedge.comLinkedin: https://www.linkedin.com/in/kleenedge/
The Michigan State University College of Engineering has launched its new Technology Engineering program. (TechE) [pronounced Tech – “E”]The TechE bachelor of science degree program was developed from the ground up with extensive input from industry. It blends mechanical, electrical, and computer engineering with computer science to prepare students for modern engineering challenges in a multidisciplinary, interconnected world.Students choose from concentrations in mechatronics and embedded cybersecurity or a smart agricultural systems minor. Courses in hardware cybersecurity, electronics and embedded systems, sensors and signal processing, and robotics, automation and controls are taught in state-of-the-art teaching labs and designed to leverage hands-on, real-world projects that integrate cutting-edge technologies with a strong foundational engineering mindset.The TechE degree program was launched in the fall of 2024 and offers a unique blend of engineering and computer science, tailored to address the engineering challenges of coding and computer science integrated into modern engineered systems. It serves as the college's latest response to industry demand for practice-ready engineers and aims to bridge the gap between engineers and computer scientists across product development teams.Janet Brelin-Fornari, Ph.D. is TechE program director. David Sanders and Heather Dashner are MSU College of Engineering alumni and Technology Engineering Industry Advisory Board members. Sanders is with Microsoft, and Dashner is with Ford Motor Company. Conversation Highlights:(1:17) - What is Technology Engineering? Describe the areas of concentration within it. (3:04) - What will this program offer that can't be found elsewhere?(4:34) - Why was it important for you to get involved with the Technology Engineering program?(5:57) – What about coding and artificial intelligence? (6:30) - What current industry needs does this program meet?(7:39) - How would your company utilize a graduate with this type of skill base?(8:44) - How did the idea for this program come about?(10:41) - How will a degree like this one help improve the talent pipeline in Michigan and the Midwest region moving forward?(13:06) - Why is Michigan State the best place to launch a new discipline like this? (13:40) – Spartan Engineers are ready to hit the ground running. (14:18) - What kind of facilities will be available to the students? Listen to “MSU Today with Russ White” on the radio and through Spotify, Apple Podcasts, and wherever you get your shows.
Peter Griffin is a Wellington-based science and technology journalist.
Let us know your thoughts. Send us a Text Message. Follow me to see #HeadsTalk Podcast Audiograms every Monday on LinkedInEpisode Title:
Can AI diagnose medical problems? How does AI help doctors? Can AI be used in medical diagnostics? How is AI impacting the practice of medicine? Our guest is Jason Wiesner, MD, chair of the imaging service line at Sutter Health. American Medical Association CXO Todd Unger hosts.
This lesson addresses parenting’s significant modern challenge: relating wisely to technology. Digital technology has dramatically changed parenting and childhood in recent decades. Parents must initially shepherd children’s technology relationship, then gradually help them learn to make wise digital decisions independently.
Farmers Evaluate PathoScan's Ag Tech: Real Feedback, Real Insights, Ep.2 Join us in episode two of 'What Farmers Want,' hosted by Danny Aberhart, where REAL-WORLD producers dive deep into evaluating innovative Ag Tech solutions. In this episode, we feature Tayeb Soomro, founder of PathoScan, pitching his microbial profiling platform, PathoBox. The technology allows early detection and management of crop diseases, potentially transforming fungicide application decisions. Hear from seasoned farmers like Matt Wallington, Kris Mayerle, Janel Delage, and Scott Maurer, among others, as they provide candid feedback, discuss the practicality, and explore the potential ROI. CEO Doug Jones from Cornerstone Credit Union shares insights on supporting Ag Tech advancements. This interactive, no-nonsense series aims to bridge the gap between Silicon Valley innovation and practical farming needs, ensuring technologies not only impress but work effectively in the field. 00:00 Introduction to What Farmers Want 01:54 Meet the Panelists 03:19 Farmers Share Crop Conditions and Innovations 09:12 Cornerstone Credit Union's Role in Ag Tech 16:32 Challenges in Ag Tech Adoption 20:24 Introducing Patho Scan and Patho Box 35:05 Challenges with Previous Device 35:44 Improvements in Sample Preparation 37:27 Cost and Pricing of the New Technology 40:12 Fungicide Decision-Making on the Farm 44:14 ROI and Cost Analysis of Fungicide Application 49:48 Future Plans and Farmer Feedback 58:26 Final Thoughts and Closing Remarks
AP correspondent Emma Burrows reports drone debris found in Ukraine indicates Russia is using new technology from Iran.
The Performance Marketing Association (PMA) released its third triennial affiliate marketing survey, revealing a booming industry. Data from eight networks, 53 publishers, and over 20,000 brands showed ad spend skyrocketing from $6 billion to $13.63 billion (a 14.42% CAGR), exceeding e-commerce growth and contributing 10% to overall US e-commerce revenue. While cashback and coupon sites remain significant, their market share decreased, likely due to the rise of card-linked offers and buy now, pay later options. These, along with influencer marketing, fueled growth, though the overall increase in market size means some sectors saw proportional decreases in share. The survey also highlighted growth in less directly correlated sectors like finance and telecom, and a slight decrease in ROAS (from 12:1 to 11:1), potentially due to a shift towards top-of-funnel traffic. Publisher sentiment shows concern about Google changes but optimism for the future.
#ThisMorning on #BRN #Wellness #2095 | #New #Technology Could Help #Treat #HearingLoss More Effectively | Daniel Sun, MD, University of Cincinnati | #Tunein: broadcastretirementnetwork.com #Aging, #Finance, #Lifestyle, #Privacy, #Retirement, #Wellness and #More - #everyday
Original Air Date: 2-20-2024 "Luddite" should never have become the epithet that it is as the Luddites were never afraid of or opposed to technological advancement, they only opposed the exploitation of workers and the degradation to society that came with the unfair distribution of the benefits of the targeted technology. Be part of the show! Leave us a message or text at 202-999-3991, message us on the infamous Signal at the handle bestoftheleft.01, or email Jay@BestOfTheLeft.com Full Show Notes Check out our new show, SOLVED! on YouTube! BestOfTheLeft.com/Support (Members Get Bonus Shows + No Ads!) Use our links to shop Bookshop.org and Libro.fm for a non-evil book and audiobook purchasing experience! Join our Discord community! SHOW NOTES Ch. 1: The New Luddites - SHIFT - Air Date 2-14-24 Ch. 2: Being a Luddite Is Good, Actually ft. Jathan Sadowski - Left Reckoning - Air Date 5-29-21 Ch. 3: Why this top AI guru thinks we might be in extinction-level trouble | The InnerView - TRT World - Air Date 1-22-24 Ch. 4: This is not good - jstoobs (TikTok) - Air Date 2-16-24 Ch. 5: The ACTUAL Danger of A.I. with Gary Marcus Part 1 - Factually! - Air Date 7-2-23 Ch. 6: The Left Luddites and the AI Accelerationists - torres - Air Date - 5-15-23 Ch. 7: Luddites Show Us The Politics Of Technology | Brian Merchant - The Majority Report - Air Date 11-21-23 Ch. 8: The ACTUAL Danger of A.I. with Gary Marcus Part 2 - Factually! - Air Date 7-2-23 Ch. 9: The anti-tech movement is back. - Alice Cappelle - Air Date 6-15-22 MUSIC (Blue Dot Sessions) SHOW IMAGE: Description: An 1812 block print of “The Leader of the Luddites” depicting a man in disheveled early 1800s clothing and missing one shoe leading other men up a hill while a building burns in the background. Credit: “The Leader of the Luddites”, Messrs | Working Class Movement Library catalog | Public Domain Produced by Jay! Tomlinson Visit us at BestOfTheLeft.com Listen Anywhere! BestOfTheLeft.com/Listen Listen Anywhere! Follow BotL: Bluesky | Mastodon | Threads | X Like at Facebook.com/BestOfTheLeft Contact me directly at Jay@BestOfTheLeft.com
Lawfare Contributing Editor Renée DiResta sits down with Daphne Keller, Director of the Program on Platform Regulation at Stanford University's Cyber Policy Center; Dean Jackson, Contributing Editor at Tech Policy Press and fellow at American University's Center for Security, Innovation, and New Technology; and Joan Barata, Senior Legal Fellow at The Future of Free Speech Project at Vanderbilt University and fellow at Stanford's Program on Platform Regulation, to make European tech regulation interesting. They discuss the European Union's Disinformation Code of Practice and its transition, on July 1, from voluntary framework co-authored by Big Tech, to legally binding obligation under the Digital Services Act (DSA). This sounds like a niche bureaucratic change—but it's provided a news hook for the Trump Administration and its allies in far-right parties across Europe to allege once again that they are being suppressed by Big Tech, and that this transition portends the end of free speech on the internet.Does it? No. But what do the Code and the DSA actually do? It's worth understanding the nuances of these regulations and how they may impact transparency, accountability, and free expression. The group discusses topics including Senator Marco Rubio's recent visa ban policy aimed at “foreign censors,” Romania's annulled election, and whether European regulation risks overreach or fails to go far enough.For more on this topic:Hate Speech: Comparing the US and EU ApproachesThe European Commission's Approach to DSA Systemic Risk is Concerning for Freedom of ExpressionThe Far Right's War on Content Moderation Comes to Europe Regulation or Repression? How the Right Hijacked the DSA DebateLawful but Awful? Control over Legal Speech by Platforms, Governments, and Internet UsersThe Rise of the Compliant Speech PlatformThree Questions Prompted by Rubio's Threatened Visa Restrictions on ‘Foreign Nationals Who Censor Americans'Will the DSA Save Democracy? The Test of the Recent Presidential Election in RomaniaTo receive ad-free podcasts, become a Lawfare Material Supporter at www.patreon.com/lawfare. You can also support Lawfare by making a one-time donation at https://givebutter.com/lawfare-institute.Support this show http://supporter.acast.com/lawfare. Hosted on Acast. See acast.com/privacy for more information.
Certified fraud examiner, Professor at Governors State University, and expert on all things fraud, William Kresse, joins Jon Hansen to discuss fake IDs. Professor Kresse discusses the amount of money students are paying for them, how the TSA is catching them, and the possible dangers of having one.
The New Jersey drones have been a topic of conversation for the last year. What were they? The current administration says it was FAA tests. The FAA has denied that. Now news nation's Ross Couothart says he has a source that says it was indeed US technology, but advanced technology that was being used to divert attention from what really is flying in the sky. Kristian Harloff gives us his thoughts. #UAP #UFO #UAP #UFOs #Government #FAA #News
Dr. Nathan Pennell and Dr. Cheryl Czerlanis discuss challenges in lung cancer screening and potential solutions to increase screening rates, including the use of AI to enhance risk prediction and screening processes. Transcript Dr. Nate Pennell: Hello, and welcome to By the Book, a monthly podcast series for ASCO Education that features engaging discussions between editors and authors from the ASCO Educational Book. I'm Dr. Nate Pennell, the co-director of the Cleveland Clinic Lung Cancer Program and vice chair of clinical research for the Taussig Cancer Center. I'm also the editor-in-chief for the ASCO Educational Book. Lung cancer is one of the leading causes of cancer-related mortality worldwide, and most cases are diagnosed at advanced stages where curative treatment options are limited. On the opposite end, early-stage lung cancers are very curable. If only we could find more patients at that early stage, an approach that has revolutionized survival for other cancer types such as colorectal and breast cancer. On today's episode, I'm delighted to be joined by Dr. Cheryl Czerlanis, a professor of medicine and thoracic medical oncologist at the University of Wisconsin Carbone Cancer Center, to discuss her article titled, "Broadening the Net: Overcoming Challenges and Embracing Novel Technologies in Lung Cancer Screening." The article was recently published in the ASCO Educational Book and featured in an Education Session at the 2025 ASCO Annual Meeting. Our full disclosures are available in the transcript of this episode. Cheryl, it's great to have you on the podcast today. Thanks for being here. Dr. Cheryl Czerlanis: Thanks, Nate. It's great to be here with you. Dr. Nate Pennell: So, I'd like to just start by asking you a little bit about the importance of lung cancer screening and what evidence is there that lung cancer screening is beneficial. Dr. Cheryl Czerlanis: Thank you. Lung cancer screening is extremely important because we know that lung cancer survival is closely tied to stage at diagnosis. We have made significant progress in the treatment of lung cancer, especially over the past decade, with the introduction of immunotherapies and targeted therapies based on personalized evaluation of genomic alterations. But the reality is that outside of a lung screening program, most patients with lung cancer present with symptoms related to advanced cancer, where our ability to cure the disease is more limited. While lung cancer screening has been studied for years, the National Lung Screening Trial, or the NLST, first reported in 2011 a significant reduction in lung cancer deaths through screening. Annual low-dose CT scans were performed in a high-risk population for lung cancer in comparison to chest X-ray. The study population was comprised of asymptomatic persons aged 55 to 74 with a 30-pack-year history of smoking who were either active smokers or had quit within 15 years. The low-dose CT screening was associated with a 20% relative risk reduction in lung cancer-related mortality. A similar magnitude of benefit was also reported in the NELSON trial, which was a large European randomized trial comparing low-dose CT with a control group receiving no screening. Dr. Nate Pennell: So, this led, of course, to approval from CMS (Centers for Medicare and Medicaid Services) for lung cancer screening in the Medicare population, probably about 10 years ago now, I think. And there are now two major trials showing an unequivocal reduction in lung cancer-related mortality and even evidence that it reduces overall mortality with lung cancer screening. But despite this, lung cancer screening rates are very low in the United States. So, first of all, what's going on? Why are we not seeing the kinds of screening rates that we see with mammography and colonoscopy? And what are the barriers to that here? Dr. Cheryl Czerlanis: That's a great question. Thank you, Nate. In the United States, recruitment for lung cancer screening programs has faced numerous challenges, including those related to socioeconomic, cultural, logistical, and even racial disparities. Our current lung cancer screening guidelines are somewhat imprecise and often fail to address differences that we know exist in sex, smoking history, socioeconomic status, and ethnicity. We also see underrepresentation in certain groups, including African Americans and other minorities, and special populations, including individuals with HIV. And even where lung cancer screening is readily available and we have evidence of its efficacy, uptake can be low due to both provider and patient factors. On the provider side, barriers include having insufficient time in a clinic visit for shared decision-making, fear of missed test results, lack of awareness about current guidelines, concerns about cost, potential harms, and evaluating both true and false-positive test results. And then on the patient side, barriers include concerns about cost, fear of getting a cancer diagnosis, stigma associated with tobacco smoking, and misconceptions about the treatability of lung cancer. Dr. Nate Pennell: I think those last two are really what make lung cancer unique compared to, say, for example, breast cancer, where there really is a public acceptance of the value of mammography and that breast cancer is no one's fault and that it really is embraced as an active way you can take care of yourself by getting your breast cancer screening. Whereas in lung cancer, between the stigma of smoking and the concern that, you know, it's a death sentence, I think we really have some work to be made up, which we'll talk about in a minute about what we can do to help improve this. Now, that's in the U.S. I think things are probably, I would imagine, even worse when we leave the U.S. and look outside, especially at low- and middle-income countries. Dr. Cheryl Czerlanis: Yes, globally, this issue is even more complex than it is in the United States. Widespread implementation of low-dose CT imaging for lung cancer screening is limited by manpower, infrastructure, and economic constraints. Many low- and middle-income countries even lack sufficient CT machines, trained personnel, and specialized facilities for accurate and timely screenings. Even in urban centers with advanced diagnostic facilities, the high screening and follow-up care costs can limit access. Rural populations face additional barriers, such as geographic inaccessibility of urban centers, transportation costs, language barriers, and mistrust of healthcare systems. In addition, healthcare systems in these regions often prioritize infectious diseases and maternal health, leaving limited room for investments in noncommunicable disease prevention like lung cancer screening. Policymakers often struggle to justify allocating resources to lung cancer screening when immediate healthcare needs remain unmet. Urban-rural disparities exacerbate these challenges, with rural regions frequently lacking the infrastructure and resources to sustain screening programs. Dr. Nate Pennell: Well, it's certainly an intimidating problem to try to reduce these disparities, especially between the U.S. and low- and middle-income countries. So, what are some of the potential solutions, both here in the U.S. and internationally, that we can do to try to increase the rates of lung cancer screening? Dr. Cheryl Czerlanis: The good news is that we can take steps to address these challenges, but a multifaceted approach is needed. Public awareness campaigns focused on the benefits of early detection and dispelling myths about lung cancer screening are essential to improving participation rates. Using risk-prediction models to identify high-risk individuals can increase the efficiency of lung cancer screening programs. Automated follow-up reminders and screening navigators can also ensure timely referrals and reduce delays in diagnosis and treatment. Reducing or subsidizing the cost of low-dose CT scans, especially in low- or middle-income countries, can improve accessibility. Deploying mobile CT scanners can expand access to rural and underserved areas. On a global scale, integrating lung cancer screening with existing healthcare programs, such as TB or noncommunicable disease initiatives, can enhance resource utilization and program scalability. Implementing lung cancer screening in resource-limited settings requires strategic investment, capacity building, and policy interventions that prioritize equity. Addressing financial constraints, infrastructure gaps, and sociocultural barriers can help overcome existing challenges. By focusing on cost-effective strategies, public awareness, and risk-based eligibility criteria, global efforts can promote equitable access to lung cancer screening and improve outcomes. Lastly, as part of the medical community, we play an important role in a patient's decision to pursue lung cancer screening. Being up to date with current lung cancer screening recommendations, identifying eligible patients, and encouraging a patient to undergo screening often is the difference-maker. Electronic medical record (EMR) systems and reminders are helpful in this regard, but relationship building and a recommendation from a trusted provider are really essential here. Dr. Nate Pennell: I think that makes a lot of sense. I mean, there are technology improvements. For example, our lung cancer screening program at The Cleveland Clinic, a few years back, we finally started an automated best practice alert in our EMR for patients who met the age and smoking requirements, and it led to a six-fold increase in people referred for screening. But at the same time, there's a difference between just getting this alert and putting in an order for lung cancer screening and actually getting those patients to go and actually do the screening and then follow up on it. And that, of course, requires having that relationship and discussion with the patient so that they trust that you have their best interests. Dr. Cheryl Czerlanis: Exactly. I think that's important. You know, certainly, while technology can aid in bringing patients in, there really is no substitute for trust-building and a personal relationship with a provider. Dr. Nate Pennell: I know that there are probably multiple examples within the U.S. where health systems or programs have put together, I would say, quality improvement projects to try to increase lung cancer screening and working with their community. There's one in particular that you discuss in your paper called the "End Lung Cancer Now" initiative. I wonder if you could take us through that. Dr. Cheryl Czerlanis: Absolutely. "End Lung Cancer Now" is an initiative at the Indiana University Simon Comprehensive Cancer Center that has the vision to end suffering and death from lung cancer in Indiana through education and community empowerment. We discuss this as a paradigm for how community engagement is important in building and scaling a lung cancer screening program. In 2023, the "End Lung Cancer Now" team decided to focus its efforts on scaling and transforming lung cancer screening rates in Indiana. They developed a task force with 26 experts in various fields, including radiology, pulmonary medicine, thoracic surgery, public health, and advocacy groups. The result of this work is an 85-page blueprint with key recommendations that any system and community can use to scale lung cancer screening efforts. After building strong infrastructure for lung cancer screening at Indiana University, they sought to understand what the priorities, resources, and challenges in their communities were. To do this, they forged strong partnerships with both local and national organizations, including the American Lung Association, American Cancer Society, and others. In the first year, they actually tripled the number of screening low-dose CTs performed in their academic center and saw a 40% increase system-wide. One thing that I think is the most striking is that through their community outreach, they learned that most people prefer to get medical care close to home within their own communities. Establishing a way to support the local infrastructure to provide care became far more important than recruiting patients to their larger system. In exciting news, "End Lung Cancer Now" has partnered with the IU Simon Comprehensive Cancer Center and IU Health to launch Indiana's first and only mobile lung screening program in March of 2025. This mobile program travels around the state to counties where the highest incidence of lung cancer exists and there is limited access to screening. The mobile unit parks at trusted sites within communities and works in partnership, not competition, with local health clinics and facilities to screen high-risk populations. Dr. Nate Pennell: I think that sounds like a great idea. Screening is such an important thing that it doesn't necessarily have to be owned by any one particular health system for their patients. I think. And I love the idea of bringing the screening to patients where they are. I can speak to working in a regional healthcare system with a main campus in the downtown that patients absolutely hate having to come here from even 30 or 40 minutes away, and they'd much rather get their care locally. So that makes perfect sense. So, under the current guidelines, there are certainly things that we can do to try to improve capturing the people that meet those. But are those guidelines actually capturing enough patients with lung cancer to make a difference? There certainly are proposals within patient advocacy communities and even other countries where there's a large percentage of non-smokers who perhaps get lung cancer. Can we expand beyond just older, current and heavy smokers to identify at-risk populations who could benefit from screening? Dr. Cheryl Czerlanis: Yes, I think we can, and it's certainly an active area of research interest. We know that tobacco is the leading cause of lung cancer worldwide. However, other risk factors include secondhand smoke, family history, exposure to environmental carcinogens, and pulmonary diseases like COPD and interstitial lung disease. Despite these known associations, the benefit of lung cancer screening is less well elucidated in never-smokers and those at risk of developing lung cancer because of family history or other risk factors. We know that the eligibility criteria associated with our current screening guidelines focus on age and smoking history and may miss more than 50% of lung cancers. Globally, 10% to 25% of lung cancer cases occur in never-smokers. And in certain parts of the world, like you mentioned, Nate, such as East Asia, many lung cancers are diagnosed in never-smokers, especially in women. Risk-prediction models use specific risk factors for lung cancer to enhance individual selection for screening, although they have historically focused on current or former smokers. We know that individuals with family members affected by lung cancer have an increased risk of developing the disease. To this end, several large-scale, single-arm prospective studies in Asia have evaluated broadening screening criteria to never-smokers, with or without additional risk factors. One such study, the Taiwan Lung Cancer Screening in Never-Smoker Trial, was a multicenter prospective cohort study at 17 medical centers in Taiwan. The primary outcome of the TALENT trial was lung cancer detection rate. Eligible patients aged 55 to 75 had either never smoked or had a light and remote smoking history. In addition, inclusion required one or more of the following risk factors: family history of lung cancer, passive smoke exposure, history of TB or COPD, a high cooking index, which is a metric that quantifies exposure to cooking fumes, or a history of cooking without ventilation. Participants underwent low-dose CT screening at baseline, then annually for 2 years, and then every 2 years for up to 6 years. The lung cancer detection rate was 2.6%, which was higher than that reported in the NLST and NELSON trials, and most were stage 0 or I cancers. Subsequently, this led to the Taiwan Early Detection Program for Lung Cancer, a national screening program that was launched in 2022, targeting 2 screening populations: individuals with a heavy history of smoking and individuals with a family history of lung cancer. We really need randomized controlled trials to determine the true rates of overdiagnosis or finding cancers that would not lead to morbidity or mortality in persons who are diagnosed, and to establish whether the high lung detection rates are associated with a decrease in lung cancer-related mortality in these populations. However, the implementation of randomized controlled low-dose CT screening trials in never-smokers has been limited by the need for large sample sizes, lengthy follow-up, and cost. In another group potentially at higher risk for developing lung cancer, the role of lung cancer screening in individuals who harbor germline pathogenic variants associated with lung cancer also needs to be explored further. Dr. Nate Pennell: We had this discussion when the first criteria came out because there have always been risk-based calculators for lung cancer that certainly incorporate smoking but other factors as well and have discussion about whether we should be screening people based on their risk and not just based on discrete criteria such as smoking. But of course, the insurance coverage for screening, you have to fit the actual criteria, which is very constrained by age and smoking history. Do you think in the U.S. there's hope for broadening our screening beyond NLST and NELSON criteria? Dr. Cheryl Czerlanis: I do think at some point there is hope for broadening the criteria beyond smoking history and age, beyond the criteria that we have typically used and that is covered by insurance. I do think it will take some work to perhaps make the prediction models more precise or to really understand who can benefit. We certainly know that there are many patients who develop lung cancer without a history of smoking or without family history, and it would be great if we could diagnose more patients with lung cancer at an earlier stage. I think this will really count on there being some work towards trying to figure out what would be the best population for screening, what risk factors to look for, perhaps using some new technologies that may help us to predict who is at risk for developing lung cancer, and trying to increase the group that we study to try and find these early-stage lung cancers that can be cured. Dr. Nate Pennell: Part of the reason we, of course, try to enrich our population is screening works better when you have a higher pretest probability of actually having cancer. And part of that also is that our technology is not that great. You know, even in high-risk patients who have CT scans that are positive for a screen, we know that the vast majority of those patients with lung nodules actually don't have lung cancer. And so you have to follow them, you have to use various models to see, you know, what the risk, even in the setting of a positive screen, is of having lung cancer. So, why don't we talk about some newer tools that we might use to help improve lung cancer screening? And one of the things that everyone is super excited about, of course, is artificial intelligence. Are there AI technologies that are helping out in early detection in lung cancer screening? Dr. Cheryl Czerlanis: Yes, that's a great question. We know that predicting who's at risk for lung cancer is challenging for the reasons that we talked about, knowing that there are many risk factors beyond smoking and age that are hard to quantify. Artificial intelligence is a tool that can help refine screening criteria and really expand screening access. Machine learning is a form of AI technology that is adept at recognizing patterns in large datasets and then applying the learning to new datasets. Several machine learning models have been developed for risk stratification and early detection of lung cancer on imaging, both with and without blood-based biomarkers. This type of technology is very promising and can serve as a tool that helps to select individuals for screening by predicting who is likely to develop lung cancer in the future. A group at Massachusetts General Hospital, represented in our group for this paper by my co-authors, Drs. Fintelmann and Chang, developed Sybil, which is an open-access 3D convolutional neural network that predicts an individual's future risk of lung cancer based on the analysis of a single low-dose CT without the need for human annotation or other clinical inputs. Sybil and other machine learning models have tremendous potential for precision lung cancer screening, even, and perhaps especially, in settings where expert image interpretation is unavailable. They could support risk-adapted screening schedules, such as varying the frequency and interval of low-dose CT scans according to individual risk and potentially expand lung cancer screening eligibility beyond age and smoking history. Their group predicts that AI tools like Sybil will play a major role in decoding the complex landscape of lung cancer risk factors, enabling us to extend life-saving lung cancer screening to all who are at risk. Dr. Nate Pennell: I think that that would certainly be welcome. And as AI is working its way into pretty much every aspect of life, including medical care, I think it's certainly promising that it can improve on our existing technology. We don't have to spend a lot of time on this because I know it's a little out of scope for what you covered in your paper, but I'm sure our listeners are curious about your thoughts on the use of other types of testing beyond CT screening for detecting lung cancer. I know that there are a number of investigational and even commercially available blood tests, for example, for detection of lung cancer, or even the so-called multi-cancer detection blood tests that are now being offered, although not necessarily being covered by insurance, for multiple types of cancer, but lung cancer being a common cancer is included in that. So, what do you think? Dr. Cheryl Czerlanis: Yes, like you mentioned, there are novel bioassays such as blood-based biomarker testing that evaluate for DNA, RNA, and circulating tumor cells that are both promising and under active investigation for lung cancer and multi-cancer detection. We know that such biomarker assays may be useful in both identifying lung cancers but also in identifying patients with a high-risk result who should undergo lung cancer screening by conventional methods. Dr. Nate Pennell: Anything that will improve on our rate of screening, I think, will be welcome. I think probably in the future, it will be some combination of better risk prediction and better interpretation of screening results, whether those be imaging or some combination of imaging and biomarkers, breath-based, blood-based. There's so much going on that it is pretty exciting, but we're still going to have to overcome the stigma and lack of public support for lung cancer screening if we're going to move the needle. Dr. Cheryl Czerlanis: Yes, I think moving the needle is so important because we know lung cancer is still a very morbid disease, and our ability to cure patients is not where we would like it to be. But I do believe there's hope. There are a lot of motivated individuals and groups who are passionate about lung cancer screening, like myself and my co-authors, and we're just happy to be able to share some ways that we can overcome the challenges and really try and make an impact in the lives of our patients. Dr. Nate Pennell: Well, thank you, Dr. Czerlanis, for joining me on the By the Book Podcast today and for all of your work to advance care for patients with lung cancer. Dr. Cheryl Czerlanis: Thank you, Dr. Pennell. It's such a pleasure to be with you today. Thank you. Dr. Nate Pennell: And thank you to our listeners for joining us today. You'll find a link to Dr. Czerlanis' article in the transcript of this episode. Please join us again next month for By the Book's next episode and more insightful views on topics you'll be hearing at the education sessions from ASCO meetings throughout the year, and our deep dives on approaches that are shaping modern oncology. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers: Dr. Nathan Pennell @n8pennell @n8pennell.bsky.social Dr. Cheryl Czerlanis Follow ASCO on social media: @ASCO on X (formerly Twitter) ASCO on Bluesky ASCO on Facebook ASCO on LinkedIn Disclosures: Dr. Nate Pennell: Consulting or Advisory Role: AstraZeneca, Lilly, Cota Healthcare, Merck, Bristol-Myers Squibb, Genentech, Amgen, G1 Therapeutics, Pfizer, Boehringer Ingelheim, Viosera, Xencor, Mirati Therapeutics, Janssen Oncology, Sanofi/Regeneron Research Funding (Institution): Genentech, AstraZeneca, Merck, Loxo, Altor BioScience, Spectrum Pharmaceuticals, Bristol-Myers Squibb, Jounce Therapeutics, Mirati Therapeutics, Heat Biologics, WindMIL, Sanofi Dr. Cheryl Czerlanis: Research Funding (Institution): LungLife AI, AstraZeneca, Summit Therapeutics
Sorry to all the Short Kings and Queens out there but it looks like Tinder has been trialing a height filter for all the singles looking for love!See omnystudio.com/listener for privacy information.
Almost three decades since the international adoption of the Mine Ban Treaty, civilians in almost 70 countries still live with the risk of landmines. About 6,000 people a year are killed and wounded globally by explosive remnants. Clearance operations remain both a dangerous and painstaking task. It can take decades to rid a country of explosive remnants, but an Australian company - in partnership with the CSIRO - has developed new technology that it says has the potential to make clearance operations faster, smarter and safer. - Операции по разминированию остаются опасной и кропотливой задачей. Австралийская компания в партнерстве с CSIRO разработала новую технологию, которая, по ее словам, может сделать операции по разминированию быстрыми и безопасными.
In this episode, Fabian Lambert, Technology Development Manager, Axens, discusses the main risks associated in developing new technologies, how demo units are utilized in scaling up new industrial technologies, and various approaches to innovation and risk management with industry partners.
Almost three decades since the international adoption of the Mine Ban Treaty, civilians in almost 70 countries still live with the risk of landmines. About 6,000 people a year are killed and wounded globally by explosive remnants. Clearance operations remain both a dangerous and painstaking task. It can take decades to rid a country of explosive remnants, but an Australian company - in partnership with the CSIRO - has developed new technology that it says has the potential to make clearance operations faster, smarter and safer.
Mark delves into ChatGPT sycophancy, faking adhd tests with AI and artificial intelligence hallucinations affecting lawsuits.
One of the promises of new technology is to simplify complex paper-based processes and create efficiencies while reducing costs and eliminating waste, fraud, and abuse. Each of the fifty states has a unique way for people to submit unemployment insurance claims. This made it a nightmare to communicate with the Department of Labor. Akanksha Sharma, Department of Labor, led a team that solved the problem through an identity verification system that could be layered over the varying state systems to have a single source of individual information, reducing waste and fraud. On the other side of the globe, family members living in on-site residences had issues with submitting claims—a similar situation, several bases, all with unique ways of processing work orders. Kevin Adler from ServiceNow outlined how a system was developed that allows individuals to make claims using their phones. Changing to a digital process enabled administrators to leverage prebuilt workflows. This transitioned away from cumbersome paper forms and enabled leaders to drastically reduce the time it takes to solve problems with military families. Both scenarios demonstrate how technology can transform a situation, facilitate feedback, and offer flexibility in reporting as well.
Episode 9-18 – Chief-Emeritus/Retired Charles Werner- New Technology for First RespondersChief-Emeritus/Retired Charles Werner has served 44 years in the fire service, 37 years with the Charlottesville Fire Dept., the last ten as the Charlottesville Fire Department. Additionally, he is also the current Executive Director of Droneresponders.org with just under 12,000 members from across the world. In our interview, Chief Werner explains recent technology that we either have now or will in the near future. A number of these will be, not only for the Fire Services, but our Brothers & Sisters of Law Enforcement and EMS!Chief Werner has also served as Acting Deputy State Coordinator and Senior Adviser with the Virginia Department of Emergency Management, where he helped to facilitate VDEM's UAS (sic. Drone), as well helping the Albermarle County Sheriff's Office SAR team. So, if you're a “techy,” “geek,” etc., this podcast is one you will not want to miss! **********Please remember that we need your help so that we can financially help a Brother, Sister, or their families in dire need. Please visit our website at https://5-AlarmTaskForceCorp.org and you'll see a photo of the Silver Siren. Please click on the picture and our donation page pops up. Choose the value and the method of paying. You'll see a small label that says, “Apply my Gift To” and please select FOUNDATION.
Kyle and Mark sit down with Detective Dave Gibson of the Tempe, Arizona Police Department to uncover how law enforcement is using cutting-edge technology by partnering with Critical Tech Solutions. Detective Gibson shares powerful insights into the tools, tactics, and real world impacts of this high stakes collaboration. =================================Subscribe to Shots Fired Podcast Here:➡️ YouTube: @shotsfiredpodcast50 ==============Ways to reach the Shots Fired Podcast Team:==============
Thanks to our Partners, NAPA TRACS, and Today's Class Recorded at the NAPA Now Conference celebrating NAPA Auto Care's 100th anniversary, this conversation dives into the realities of emerging automotive technologies, especially ADAS (Advanced Driver-Assistance Systems). The discussion emphasizes the critical need for proper calibration procedures, equipment, and technician training to keep pace with rapidly evolving tech. From static vs. dynamic calibrations to the integration of AR/VR tools, the panel explores the industry's struggles to adopt new technology and the personal traits, like hyperfocus, needed to thrive in today's complex diagnostic landscape. The takeaway: adaptation, education, and investment are no longer optional; they're essential for staying competitive. Bill Weaver, NAPA Autotech Trainer. Listen to Bill's previous episodes HERE Matt Fanslow, Riverside Automotive, Red Wing, MN, Diagnosing the Aftermarket A to Z Podcast Show Notes: Watch Full Video Episode Introduction to Town Hall Academy (00:00:00) NAPA's 100-Year Legacy (00:01:19) Emerging Technologies in Automotive (00:04:29)r. ADAS Calibration Challenges (00:08:06) Industry Ignorance Towards ADAS (00:11:11) Frustration with Industry Changes (00:13:01) Fear of New Technologies (00:14:44) Calibration Concerns (00:18:06) Dynamic Calibration Challenges (00:18:19) Legal Implications of Calibration (00:20:02) Tire Repair Liability (00:20:25) Importance of Following Procedures (00:21:24) ADAS Responsibility (00:24:01) Collaboration Among Shops (00:25:40) Cost of Living Awareness (00:27:16) Spinning Plate Syndrome (00:31:06) ADHD and Hyperfocus (00:35:27) Job Security and Continuous...
Beyond The Outer Realm UNCENSORED welcomes back dear friend and fellow UPRN Host of Ethereal Encounters Unveiled, Carolann Iadarola Host: Michelle Desrochers Date: May 20th, 2025 Episode: 564 Discussion : Uncensored Segment - Join Carolann and I for another Uncensored as we delve deeper into MORE MORE MORE - Conspiracies, Forbidden Knowledge, Ancient and NEW Technologies, and thats just getting us started Contact for the show - theouterrealmcontact@gmail.com Rumble: TheOuterRealm X - MicheleDerocher Website: www.theouterrealmradio.com Please support us by Liking, Subscribing, Sharing and Commenting. Thank you all !!!- About Carolann: Bio After a lifetime of exploring high strangeness and living life as an empath, she embarked on a new journey with Ethereal Encounters Unveiled to share opinions, experiences, and powerful insights from authors, ufologists, psychics, and otherswho have stepped inside unknown universes. Carolann Iadarola owns and is also the author of Sassy Townhouse Living, a lifestyle website dedicated to sharing innovative ideas and resources in home decor, food, beauty, and overall living. She holds a master's degree in education (M.Ed.) in Instructional Technologies and Instructional Design from East Stroudsburg University of Pennsylvania. Her show features an eclectic mix of guests with unique perspectives and experiences from the paranormal world. Hergoal is for you to embark on a journey that will leave you spellbound, enlightened, and even forever transformed. Every week, you will meet authors, ufologists, spiritualists, light workers, and people from varying walks of life. Ethereal Encounters Unveiled is your gateway to the unseen and the mystical. Dive into the world of the paranormal, supernatural, and inexplicable. Whether you're a skeptic, a believer, or simply curious, travel with us beyond the veil to discover the mysteries that lie beyond our grasp. If you enjoy the content on the channel, please support us by subscribing: Thank you All A formal disclosure: The opinions and information presented or expressed by guests on The Outer Realm Radio and Beyond The Outer Realm are not necessarily those of the TOR, BTOR Hosts, Sponsors, or the United Public Radio Network and its producers. Although the content may be interesting, it is deemed "For Entertainment Purposes" . We are always be respectful and courteous to all involved. Thank you, we appreciate you all!
Bill has been at the TUANZ conference in Hamilton where they've been discussing why 100% of New Zealanders aren't connected.
AAA projected more than 45 million people will travel at least 50 miles from home over the Memorial Day holiday period. With many set to fly to their destinations, we asked the Connecticut Airport Authority how Bradley International Airport is preparing. We also highlighted new technology at Bradley making the airport experience better for travelers, called GoodMaps. Image Credit: Getty Images
Tony discusses a recent randsomware attack on an Australian construction firm where 17 GB of corporate data was allegedly taken; the US Justice Department has unsealed indictments against 12 individuals, so called "hackers for hire; and New Zealand has seen a dramatic 68% increase in sextortion cases in the first three months of the year, according to Netsafe. Tony Grasso is Principal Consultant at cybersecurity firm TitaniumDefence. He worked at GCHQ in the UK and is a former Intelligence Officer in New Zealand.
Tim and Armand are discussing how much new technology affects watch collectors. Whether it's the use of silicon, the rise of ceramic, or the possibile advent of AI in engineering, the duo discuss how changes in watchmaking might affect the industry in the future. Please Subscribe: https://www.youtube.com/@1916company/?sub_confirmation=1 Download the app: https://onelink.to/8u2bgh Buy Watches Here: https://www.the1916company.com View hands-on luxury watch reviews on The 1916 Company Watch Reviews: https://www.youtube.com/@the1916companywatchreviews/?sub_confirmation=1 Instagram: https://www.instagram.com/the1916company 00:00 Introduction 02:44 Use of Silicon 15:45 CNC Machines 20:28 Ceramic 23:53 Connected Watches 28:58 Plastic in Watches 30:30 Quartz and Electronic Watches 44:35 Disposable Componets 49:12 AI in Watchmaking
WHOOP 5.0 and WHOOP MG have arrived. On this episode of the WHOOP Podcast, WHOOP Founder and CEO Will Ahmed sits down with Chief Product Officer Ed Baker to unpack the all-new WHOOP experience. They introduce the new devices — 5.0 and MG — and break down the three new WHOOP memberships. From 14+ day battery life to powerful new features like on-demand ECG readings, daily Blood Pressure Insights, Healthspan, and Women's Hormonal Insights, this episode covers it all. Plus, get a first look at our new WHOOP Apparel & Accessories. Whether you're upgrading or just getting started, this is your guide to everything 5.0 and MG.(00:00) Say Hello to WHOOP 5.0 and WHOOP MG(00:13) 4.0 vs 5.0: Hardware Advancements (00:52) 14-Day Battery Life and The New Wireless Powerpack(02:18) WHOOP MG(04:47) Healthspan and WHOOP Age(11:35) Heart Screener with ECG(14:37) Blood Pressure Insights(16:07) VO2 Max(17:30) New and Improved Women's Health Features(19:03) Advanced Sleep Metrics(22:06) Navigation and App Insights(24:25) Accessories and Apparel: A New Look For WHOOP(27:59) WHOOP Membership Tiers Breakdown(36:13) Gift Kit & Upgrade Benefits(37:33) Will & Ed's Favorite WHOOP MetricGet your WHOOP 5.0 now at WHOOP.comThe ECG feature is not intended for users with known arrhythmias other than AFib or users under 22 years old. It is not recommended for users with a cardiac pacemaker, ICDs, or other implanted electronic devices. This is a medically regulated feature and is not currently available in every region. Go to https://www.whoop.com/feature-availability/ to check if it's available in your region.Blood Pressure Insights is not a medical device and cannot diagnose or manage medical conditions. It does not provide medical advice. Always consult your doctor for health concerns and never delay or modify medical care based on its information. Menstrual Cycle Insights should not be used for conception or contraception, and all phases, including the ovulatory phase, are estimates. Menstrual Cycle Insights is not a medical device and cannot diagnose or manage medical conditions. It does not provide medical advice. Always consult your doctor for health concerns and never delay or modify medical care based on its information.Healthspan is not available for users under the age of 18.Support the showFollow WHOOP: www.whoop.com Trial WHOOP for Free Instagram TikTok X Facebook LinkedIn Follow Will Ahmed: Instagram X LinkedIn Follow Kristen Holmes: Instagram LinkedIn Follow Emily Capodilupo: LinkedIn
Our podcast guests are Nadya Mason and Jeffrey Spangenberger
Withered technology and Lindy Effect - two big picture concepts about tried and true developments.
Sinéad Hussey, Midlands Correspondent, has been to the Shannon Callow south of Athlone to find out more the corncrake project.
In this episode of The Wealthy Way podcast, I sit down with Robert Wensley, the CEO of Investorlift, the #1 real estate software for selling off-market properties (also known as dispositions). We dive into everything from the current state of the wholesaling industry to how technology, like AI, is reshaping the real estate market. Robert shares some amazing insights on how Investorlift is adapting to market changes, including their new free version and AI updates. We also talk about the impact of PPC (pay-per-click) marketing and how the market shifts are affecting wholesalers. Plus, Robert offers some fascinating thoughts on how technology—like Tesla's supercharging network and AI bots—can change the way we live and work. We also get into some big picture topics like Trump's executive orders, the future of living costs, and the role of technology in lowering those costs. You don't want to miss Robert's take on how the job market is changing and why innovation is the key to moving forward. If you're an entrepreneur, especially in real estate, you'll walk away from this episode with a ton of valuable tips and insights that can help you grow your business, stay ahead of the trends, and maintain balance in life. Tune in now for a great conversation with Robert Wensley! Connect with Robert: Website: https://admin.investorlift.com/register?code=zxeTVP5p IG: https://www.instagram.com/robertwensley/ YouTube: @investorlift Get access to our real estate community, coaching, courses, and events at Wealthy University https://www.wealthyuniversity.com/Join our FREE community, weekly calls, and bible studies for Christian entrepreneurs and business people. https://www.wealthykingdom.com/ If you want to level up, text me at 725-527-7783!--- About Ryan Pineda: Ryan Pineda has been in the real estate industry since 2010 and has invested in over $100,000,000 of real estate. He has completed over 700 flips and wholesales, and he owns over 650 rental units. As an entrepreneur, he has founded seven different businesses that have generated 7-8 figures of revenue. Ryan has amassed over 2 million followers on social media and has generat...
In this episode of the Coaching 101 Podcast, hosts Daniel Chamberlain and Kenny Simpson delve into the incorporation of quarterback run games in football offensive strategies. They discuss their transition to new live streaming technology, share insights from their recent coaching clinics, and highlight key benefits of having a running quarterback. The episode also touches on product sponsors such as Ace Sports and Athletic Speed Movement and features valuable coaching tips for simplifying complex football concepts. Additional special segments include discussions about recent books by Kenny Simpson and details on upcoming coaching clinics.00:00 Introduction to Coaching 101 Podcast00:33 New Technology and Going Live02:01 Quote of the Week: Commitment03:26 Efficiency in Your Football Program05:10 Sponsorships and Promotions06:25 Upcoming Clinics and Events11:12 Quarterback Run Game Strategies22:31 Transitioning to Dual Threat Quarterbacks23:16 Adapting Playbooks for Different Quarterbacks25:20 Balancing Quarterback and Running Back Roles29:11 Incorporating Quarterback Runs into Existing Offenses37:03 Maximizing Quarterback Potential40:53 Closing Remarks and Future Plans
Today on The Egg Whisperer Show, I'm excited to have Dr. Angie Beltsos joining me to talk about new technology in egg and embryo freezing. She is the Chief Executive Physician of Kindbody, and formerly the CEO of Vios Fertility Institute. This year, her practice announced that they would be the first to use new technology to freeze and store both eggs and embryos. TMRW Life Sciences offers new advancements for freezing, monitoring, and storing our most precious cells. We also talk about their upcoming app, and her background in fertility medicine. I am really honored to have her on to talk to her about these advancements that really do change the fertility medicine landscape. Read the full show notes and transcript at Dr. Aimee's website. You can find Dr. Angie Beltsos at Kindbody, by clicking here. Do you have questions about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, April 21, 2025 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom. Click to find The Egg Whisperer Show podcast on your favorite podcasting app. Watch videos of Dr. Aimee answer Ask the Egg Whisperer Questions on YouTube. Sign up for The Egg Whisperer newsletter to get updates Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.